These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 371633)

  • 41. Gamma-irradiation of pretransplant blood transfusions from unrelated donors prevents sensitization to minor histocompatibility antigens on dog leukocyte antigen-identical canine marrow grafts.
    Bean MA; Graham T; Appelbaum FR; Deeg HJ; Schuening F; Sale GE; Storb R
    Transplantation; 1994 Feb; 57(3):423-6. PubMed ID: 8108879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
    Ildstad ST; Wren SM; Oh E; Hronakes ML
    Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gamma radiation of blood products prevents rejection of subsequent DLA-identical marrow grafts. Tolerance versus abrogation of sensitization to non-DLA antigens.
    Bean MA; Graham T; Appelbaum FR; Deeg HJ; Schuening F; Sale GE; Leisenring W; Pepe M; Storb R
    Transplantation; 1996 Jan; 61(2):334-5. PubMed ID: 8600648
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of time on sensitization to hemophoietic grafts by preceding blood transfusion.
    Weiden PL; Storb R; Kolb HJ; Graham TC; Kao G; Thomas ED
    Transplantation; 1975 Mar; 19(3):240-4. PubMed ID: 1094638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of fractionated to single-dose total body irradiation in conditioning canine littermates for DLA-identical marrow grafts.
    Storb R; Raff RF; Appelbaum FR; Graham TC; Schuening FG; Sale G; Pepe M
    Blood; 1989 Aug; 74(3):1139-43. PubMed ID: 2665864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transplantation analysis of B cell destruction in (NOD x CBA)F1 mouse bone marrow chimeras.
    Serreze DV; Leiter EH; Shultz LD
    Diabetologia; 1990 Feb; 33(2):84-92. PubMed ID: 2109714
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetically determined resistance to foreign bone marrow transplantation in mice: characterization of the effector cells.
    Miller SC
    J Immunol; 1983 Jul; 131(1):92-7. PubMed ID: 6345669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preceding transfusions and marrow graft rejection in dogs and man.
    Weiden PL; Storb R; Thomas ED; Graham TC; Lerner KG; Buckner CD; Fefer A; Neiman PE; Clift RA
    Transplant Proc; 1976 Dec; 8(4):551-4. PubMed ID: 793113
    [No Abstract]   [Full Text] [Related]  

  • 49. Induction of unresponsiveness to major transplantable organs in adult mammals: a recapitulation of ontogeny by irradiation and bone marrow replacement.
    Rapaport FT; Bachvaroff RJ; Mollen N; Hirasawa H; Asano T; Ferrebee JW
    Ann Surg; 1979 Oct; 190(4):461-73. PubMed ID: 384942
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Marrow grafts between canine litter-mates homozygous or heterozygous for lymphocyte-defined histocompatibility antigens.
    Storb R; Weiden PL; Schroeder ML; Graham TC; Lerner KG; Thomas ED
    Transplantation; 1976 Apr; 21(4):299-306. PubMed ID: 7864
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bone marrow-derived T lymphocytes responsible for allograft rejection.
    Senjanović M; Marusić M
    Cell Immunol; 1984 Aug; 87(1):225-30. PubMed ID: 6204774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Traffic of lymphocytes in the thoracic duct and renal lymph after allotransplantation and in immunosuppression.
    Evans CM; Blamey RW; Elston CW
    Transplantation; 1978 Dec; 26(6):382-7. PubMed ID: 366821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of established graft-versus-host disease in dogs by antithymocyte serum or prednisone.
    Storb R; Kolb HJ; Graham TC; Kolb H; Weiden PL; Thomas ED
    Blood; 1973 Oct; 42(4):601-9. PubMed ID: 4591632
    [No Abstract]   [Full Text] [Related]  

  • 54. Interaction of thymus lymphocytes with histoincompatible cells. 3. Immunological characteristics of recirculating lymphocytes derived from activated thymus cells.
    Sprent J; Miller JF
    Cell Immunol; 1972 Feb; 3(2):213-30. PubMed ID: 4400932
    [No Abstract]   [Full Text] [Related]  

  • 55. Human marrow transplantation.
    Storb R; Thomas ED
    Transplantation; 1979 Jul; 28(1):1-3. PubMed ID: 36692
    [No Abstract]   [Full Text] [Related]  

  • 56. Fetal liver cell transplantation in dogs: results with DLA-compatible and incompatible grafts.
    Champlin R; Cain G; Stitzel KA; Gale RP
    Prog Clin Biol Res; 1985; 193():195-204. PubMed ID: 2868458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Canine radiation chimeras: an attempt to demonstrate serum blocking factors by an in vivo approach.
    Schroeder ML; Storb R; Graham TC; Weiden PL
    J Immunol; 1975 Feb; 114(2 Pt 1):540-1. PubMed ID: 1091700
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Marrow graft studies in dogs.
    Storb R; Weiden PL; Deeg HJ; Torok-Storb B; Atkinson K; Graham TC; Thomas ED
    Haematol Blood Transfus; 1980; 25():43-52. PubMed ID: 7021360
    [No Abstract]   [Full Text] [Related]  

  • 59. Treatment of renal allograft rejection in dogs. Combined thoracic duct fistula and immunosuppressive chemotherapy.
    Vega RE; Daniele RP; Chaya A; Mitsouka H; Howard JM
    Arch Surg; 1968 Mar; 96(3):344-8. PubMed ID: 4868532
    [No Abstract]   [Full Text] [Related]  

  • 60. Cyclosporin A and methotrexate in canine marrow transplantation: engraftment, graft-versus-host disease, and induction of intolerance.
    Deeg HJ; Storb R; Weiden PL; Raff RF; Sale GE; Atkinson K; Graham TC; Thomas ED
    Transplantation; 1982 Jul; 34(1):30-5. PubMed ID: 6750877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.